We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+2.87%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$5.45B
AUM Growth
+$2.36B
Cap. Flow
+$2.34B
Cap. Flow %
42.99%
Top 10 Hldgs %
5.62%
Holding
2,708
New
491
Increased
1,179
Reduced
746
Closed
280

Top Buys

Rank Stock Value
1
PAYX icon
Paychex
PAYX
+$37.5M
2
MO icon
Altria Group
MO
+$31.8M
3
CIEN icon
Ciena
CIEN
+$28.6M
4
LYB icon
LyondellBasell Industries
LYB
+$27.8M
5
VEEV icon
Veeva Systems
VEEV
+$26.5M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$25.3M
2
CMS icon
CMS Energy
CMS
+$16.5M
3
HUM icon
Humana
HUM
+$15.1M
4
NOC icon
Northrop Grumman
NOC
+$13.9M
5
SYY icon
Sysco
SYY
+$13.7M

Sector Composition

Rank Sector Weight
1 Technology 16.52%
2 Healthcare 13.04%
3 Financials 12.67%
4 Consumer Discretionary 12.62%
5 Industrials 12.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEDL
2226
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$105K ﹤0.01%
10,325
-3,401
-25% -$33.5K
CLLS
2227
Cellectis
CLLS
$281M
$103K ﹤0.01%
+6,601
New +$118K
CRWD icon
2228
CrowdStrike
CRWD
$214B
$103K ﹤0.01%
+6,008
New +$102K
VERI icon
2229
Veritone
VERI
$112M
$103K ﹤0.01%
12,371
-8,600
-41% -$63.9K
TLND
2230
DELISTED
Talend S.A. American Depositary Shares
TLND
$103K ﹤0.01%
2,663
+1,693
+175% +$79K
BCRX icon
2231
BioCryst Pharmaceuticals
BCRX
$2.31B
$102K ﹤0.01%
27,016
+15,924
+144% +$95.8K
TRMB icon
2232
Trimble
TRMB
$13.7B
$102K ﹤0.01%
2,269
-3,923
-63% -$163K
FATE icon
2233
Fate Therapeutics
FATE
$303M
$100K ﹤0.01%
4,948
+2,086
+73% +$37.6K
MTDR icon
2234
Matador Resources
MTDR
$5.84B
$100K ﹤0.01%
5,053
-193,606
-97% -$3.68M
SDRL
2235
DELISTED
Seadrill Limited Common Stock
SDRL
$100K ﹤0.01%
24,139
+10,746
+80% +$70.6K
NWBI icon
2236
Northwest Bancshares
NWBI
$2.34B
$97K ﹤0.01%
+5,500
New +$94.4K
CVRS
2237
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$97K ﹤0.01%
+32,482
New +$81.4K
INO icon
2238
Inovio Pharmaceuticals
INO
$70M
$96K ﹤0.01%
2,734
+1,596
+140% +$63.4K
TLPH icon
2239
Talphera
TLPH
$70.1M
$95K ﹤0.01%
+1,880
New +$113K
TRGP icon
2240
Targa Resources
TRGP
$55.8B
$95K ﹤0.01%
2,421
-17,329
-88% -$688K
TAST
2241
DELISTED
Carrols Restaurant Group, Inc.
TAST
$95K ﹤0.01%
10,570
LTM
2242
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$94K ﹤0.01%
10,080
-6,460
-39% -$62.1K
CHAP
2243
DELISTED
Chaparral Energy, Inc.
CHAP
$93K ﹤0.01%
19,681
+2,145
+12% +$10.7K
FTSI
2244
DELISTED
FTS International, Inc. Common Stock
FTSI
$93K ﹤0.01%
+836
New +$138K
MCHX icon
2245
Marchex
MCHX
$80.6M
$92K ﹤0.01%
+19,523
New +$93.3K
MGNI icon
2246
Magnite
MGNI
$2.96B
$92K ﹤0.01%
14,400
-89,001
-86% -$547K
GNRC icon
2247
Generac Holdings
GNRC
$12.8B
$90K ﹤0.01%
1,296
-4,016
-76% -$235K
KLIC icon
2248
Kulicke & Soffa
KLIC
$4.91B
$90K ﹤0.01%
4,000
-7,759
-66% -$170K
ADAM
2249
Adamas Trust
ADAM
$848M
$90K ﹤0.01%
+3,628
New +$89.6K
TPTX
2250
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$90K ﹤0.01%
+2,215
New +$79K

Similar funds

Cubist Systematic Strategies's Q2 2019 Portfolio in Review

As of Q2 2019, Cubist Systematic Strategies held 2,708 positions worth $5.45B, up 76% from $3.09B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Cubist Systematic Strategies deployed $2.34B of net new capital in Q2 2019, opening 491 new positions and adding to 1,179 existing holdings. Its largest new stake was Alexandria Real Estate Equities: 126,551 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $25.3M trimmed.

  • Cubist Systematic Strategies's largest Q2 2019 buy was Alexandria Real Estate Equities: 126,551 shares worth $17.9M.
  • Cubist Systematic Strategies added most to Paychex in Q2 2019, an estimated $37.5M increase.
  • Cubist Systematic Strategies's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $25.3M.
  • Cubist Systematic Strategies fully exited Henry Schein in Q2 2019, selling an estimated $7.04M.
  • Cubist Systematic Strategies's ten largest holdings make up 5.6% of its $5.45B portfolio in Q2 2019.
  • Cubist Systematic Strategies opened 491 new positions and closed 280 in Q2 2019.
  • Cubist Systematic Strategies's portfolio value rose 76% quarter-over-quarter to $5.45B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2019, filed 14 Aug 2019.